Pathogenic Yersinia translocates effector proteins into target cells via a type III secretion system (TTSS), modulating the host immune response. A component of the TTSS translocon, LcrV, has been implicated in preventing inflammation through Toll-like receptor 2 (TLR2) by inducing expression of the anti-inflammatory cytokine interleukin-10 (IL-10). TLR2 ؊/؊ mice were reported to be less susceptible to the enteropathogen Yersinia enterocolitica. To determine whether TLR2 also plays a role in recognition of the enteropathogen Yersinia pseudotuberculosis and whether this results in an immune response that is detrimental to the host, we evaluated the macrophage cytokine response to live Y. pseudotuberculosis and analyzed the susceptibility of TLR2 ؊/؊ mice to enteropathogenic Yersinia. We find that Yersinia induction of macrophage IL-10 occurs independently of TLR2 and LcrV and is blocked by the TTSS. In particular, the TTSS effector protein YopJ, which inhibits production of the inflammatory cytokine tumor necrosis factor alpha (TNF-␣), also inhibits IL-10 expression. Consistent with these results, IL-10 is undetectable in Y. pseudotuberculosis-infected mouse tissues until advanced stages of infection. In addition, we find that TLR2 ؊/؊ mice (derived independently from those used in previous studies) do not display altered susceptibility to enteropathogenic Yersinia compared to wild-type mice. Tissue levels of IL-10, as well as the inflammatory cytokines TNF-␣, IL-6, and gamma interferon and the chemokine macrophage chemotactic protein 1, are similar in TLR2 ؉/؉ and TLR2 ؊/؊ mice during enteropathogenic Yersinia infection. Therefore, the absence of TLR2 alone does not affect the cytokine response of macrophages to, or the in vivo growth and survival of, enteropathogenic Yersinia.
Yersinia pestis, the causative agent of bubonic plague, has caused extensive human mortality, killing an estimated 200 million people (43) . The related food-borne pathogens Yersinia pseudotuberculosis and Yersinia enterocolitica express many of the same virulence factors as Y. pestis yet cause gastroenteritis and lymphadenitis (37, 58) . These shared virulence factors include a type III secretion system (TTSS) encoded by a plasmid (called pYV in enteropathogenic Yersinia). The components of the TTSS apparatus as well as its effector Yops (Yersinia outer membrane proteins) have been linked to immunomodulation of the mammalian immune system (10) . Numerous studies have shown that effector Yops interfere with innate immune functions such as phagocytosis and cytokine release by cultured cells in vitro (37, 58) . In addition, LcrV, a component of the TTSS translocon, has been reported to inhibit inflammation both in vivo and in vitro (10, 36, 41, 49) .
LcrV, also known as V antigen, is important in controlling the expression levels of TTSS components (7, 46) . In addition, LcrV is thought to cooperate with two other proteins at the tip of the TTSS needle to facilitate the translocation of effector Yops into host cells, allowing these effectors access to their mammalian targets (13, 34, 39, 44) . Consistent with its essential role in Yersinia virulence, LcrV represents a major protective antigen against Yersinia infection. Injection of a purified chimeric protein derived from the 259-amino-acid C-terminal portion of Y. pseudotuberculosis LcrV induces passive immunity to Y. pestis or Y. pseudotuberculosis (33) . This same recombinant immunogen was also shown to inhibit the production of inflammatory cytokines when injected into mice infected with plasmid-free (pYV Ϫ ) Yersinia (36) . More recently, purified LcrV from Y. pestis was shown to induce expression of the anti-inflammatory cytokine interleukin-10 (IL-10) in cultured macrophages (41) . Deletions within either the C terminus or the central region, but not the N terminus, of Y. pestis LcrV were associated with reduced IL-10 secretion. In contrast, a separate study demonstrated that a moiety within the Y. enterocolitica LcrV N terminus, which is missing in the Y. pseudotuberculosis LcrV immunogen, elicits IL-10 production dependent upon the presence of the innate immune sensor Toll-like receptor 2 (TLR2) (48, 50) .
TLR signaling is used largely by cells of the innate immune system to detect the presence of microbes. Thus far, 13 mammalian TLRs have been described, with each TLR recognizing a discrete set of molecules produced by bacteria, viruses, fungi, or parasites that are typically conserved components necessary for microbial life (16) . TLR2 recognizes a number of microbial molecules, including lipoproteins, lipoteichoic acid (LTA), peptidoglycan, and the yeast cell wall polysaccharide zymosan, among others (60) . Controversy over the nature of TLR2 ligands remains, primarily because lipoproteins and LTA are ligands for TLR2 and can easily contaminate preparations of other molecules (56) . However, a recent study demonstrated that peptidoglycan from Staphylococcus aureus can activate TLR2 in the absence of lipoprotein or LTA contaminants (11) .
IL-10 plays a crucial role in limiting inflammatory responses while promoting other immune processes (2). IL-10 inhibits macrophage inflammation and cell-mediated immunity yet facilitates the humoral immune response by promoting Bcell function. One major source of IL-10 in vivo is the macrophage, and IL-10 can be expressed by macrophages downstream of TLR ligands such as lipopolysaccharide (LPS) (1, 18) . This may serve to temper the inflammatory effects of other TLR-induced cytokines such as tumor necrosis factor alpha (TNF-␣).
Sing et al. (50, 51) reported that treatment of macrophages with recombinant Y. enterocolitica LcrV activates the transcription factor NF-B and induces the expression of IL-10 in a TLR2-dependent manner. The induction of IL-10 was linked to a single residue within the LcrV N terminus (K42) (48) . In line with these in vitro results, mice lacking TLR2 were reported to produce less splenic IL-10 and more of the inflammatory cytokine TNF-␣ than wild-type mice during infection with Y. enterocolitica, predicting that these mice should have enhanced resistance to this pathogen resulting from increased inflammation. In fact, TLR2 Ϫ/Ϫ mice were shown to be more resistant to infection with Y. enterocolitica serogroup O:8 strain WA-314 than TLR2 ϩ/ϩ mice (50) . Those authors explained the intriguing resistance of TLR2 Ϫ/Ϫ mice, which was observed in either the C57BL/6 or 129 murine genetic background, by proposing a model in which LcrV specifically induces IL-10 expression via TLR2, thereby dampening any inflammatory cytokine response. The significance of this result is unclear, however, because the resistance phenotype was lost after backcrossing of the TLR2 Ϫ/Ϫ mutation into the C3H background (51). In addition, although LcrV from Y. pseudotuberculosis contains the putative TLR2-activating K42 residue, recombinant Y. pseudotuberculosis LcrV does not induce IL-10 in vitro (48) .
In order to assess the significance of TLR2 and IL-10 during Y. pseudotuberculosis infection, we examined the cytokine response of primary cultured macrophages to live Y. pseudotuberculosis and the susceptibility of mice to enteropathogenic Yersinia in the presence or absence of TLR2. Modulation of IL-10 was found to occur independently of both TLR2 and LcrV during infection of macrophages. Furthermore, wild-type and TLR2
Ϫ/Ϫ mice derived independently from mice used in previous studies showed a similar level of susceptibility to enteropathogenic Yersinia infection.
MATERIALS AND METHODS

Animals. TLR2
Ϫ/Ϫ mice were a kind gift from S. Akira and were originally described by Takeuchi et al. (54) . Mice were bred into the C57BL/6 background for 10 generations and were housed under sterile conditions. Age-and sexmatched C57BL/6 control as well as IL-10 Ϫ/Ϫ mice were obtained from The Jackson Laboratory.
Bacterial strains and LcrV sequencing. Y. pseudotuberculosis strains used in this study were derived from the serogroup III clinical isolate IP2666 (8) , while the Y. enterocolitica strain was serogroup O:8 strain 8081 (45) . JMB111, referred to here as the pYV Ϫ strain, is a plasmid-cured derivative of IP2666 (5). IP2666pIB1 is Y. pseudotuberculosis IP2666 cured of its endogenous virulence plasmid and instead carries pYV from the well-characterized Y. pseudotuberculosis YPIII strain (pIB1) (8) . MLF36 (14) , referred to here as the ⌬yopJ mutant, is an IP2666pIB1 derivative that harbors an in-frame deletion of yopJ and a single point mutation within YopH (20) , creating a novel NdeI site. We have found that this point mutation does not affect YopH function, based on virulence in the mouse model and an assay for cytokine signaling in cell culture (yopH Nde ) (data not shown). To sequence the N-terminal portion of LcrV from Y. enterocolitica 8081 and Y. pseudotuberculosis IP2666pIB1, single-colony PCR was performed using Taq polymerase (Invitrogen) and the primer pair LcrV1F (5Ј-ACTTATC CGAGCAGGTGGTG-3Ј) and LcrV1R (5Ј-TGAAAATCACTCTTGGTGGG-3Ј). The resulting products were used as templates for sequencing with primers LcrVF/R, described previously (48) .
Cell and bacterial culture. Bone marrow-derived macrophages (BMDMs) were prepared as previously described (3) and determined to be free of Mycoplasma contamination by using the MycoSensor PCR assay kit (Stratagene). Freshly harvested BMDMs were used for in vitro infections, and excess BMDMs were frozen in L-cell conditioned medium supplemented with 10% dimethyl sulfoxide and 10% extra fetal bovine serum (HyClone) for future use. Results were similar when fresh or frozen BMDMs were used (data not shown). Y. pseudotuberculosis strains were grown in 2ϫ YT overnight at 26°C with agitation for incubation with cultured macrophages. The overnight cultures were diluted 1:40 into 2ϫ YT containing 20 mM sodium oxalate and 20 mM MgCl 2 , grown at 26°C for 2 h with agitation, and transferred to 37°C for an additional 2 h with agitation to induce the expression of the type III secretion system (29) . For mouse inoculation studies, Y. pseudotuberculosis and Y. enterocolitica strains were grown in L broth at 26°C with agitation for approximately 17 h. The presence of the virulence plasmid in Y. pseudotuberculosis L broth cultures was verified by the presence of YadA-dependent cell clumping after growth at 37°C in RPMI as visualized under ϫ40 magnification. Bacterial cultures were diluted in phosphate-buffered saline (PBS) to achieve the concentrations described below before infection of mice.
Analysis of BMDM response to Y. pseudotuberculosis. Fresh or previously frozen BMDMs from TLR2 ϩ/Ϫ and TLR2 Ϫ/Ϫ mice were seeded onto tissue culture-treated 24-well plates at 5 ϫ 10 5 cells per ml in Dulbecco's modified Eagle medium (Gibco) supplemented with 10% fetal bovine serum and L-glutamine (Gibco). Cell monolayers were incubated overnight in a humidified 37°C incubator. Bacteria were prepared as described above to maximize Yop expression, added to BMDMs at a multiplicity of infection of 5, and spun onto the monolayers at 1,000 rpm for 5 min. Monolayers were incubated at 37°C with 5% CO 2 for 2 h. Alternatively, BMDMs were incubated with the synthetic lipopeptide Pam 3 Cys-SKKKK (1-g/ml final concentration; EMC Microcollections) for 4 h to verify the presence of TLR2 signaling in TLR2 ϩ/Ϫ BMDMs and the loss of this signaling in TLR2 Ϫ/Ϫ BMDMs (see Fig. 5C ). Supernatants for enzymelinked immunosorbent assay (ELISA) were collected and frozen at Ϫ80°C before analysis.
Animal inoculation studies. Seven-to 9-week-old C57BL/6, TLR2 ϩ/Ϫ , and TLR2 Ϫ/Ϫ mice were used for intraperitoneal (i.p.) and oral infections. For i.p. infections, bacteria were prepared as described above and inoculation doses of 10 4 Y. enterocolitica and 2 to 6 ϫ 10 3 Y. pseudotuberculosis organisms in a 100-l volume of PBS were used. Mice were euthanatized at 4 to 5 days postinoculation for Y. pseudotuberculosis and at 4 to 8 days postinoculation for Y. enterocolitica. For oral infections, mice were starved overnight (water was given ad libitum) and 100 l 5% sodium bicarbonate was orally administered. Mice were then orogastrically inoculated with 4 ϫ 10 7 Y. enterocolitica organisms in a 200-l volume, using a feeding needle. Mice were again given food and water ad libitum and were euthanatized at 5 days postinoculation. Portions of isolated spleens and livers were homogenized for 30 s in PBS for determination of CFU and for 20 s in 1% CHAPS {3-[(3-cholamidopropyl)-dimethylamminio]-1-propanesulfonate} (Sigma) in PBS for cytokine analysis using an OMNI International homogenizer. Tissue samples for cytokine analysis were frozen at Ϫ80°C. For one of the three Y. pseudotuberculosis growth curve experiments (Fig. 1A) , organs for CFU determination were homogenized in 0.2% NP-40 instead of PBS. Homogenizing in PBS or NP-40 did not lead to significant differences in CFU (data not shown). Samples for CFU determination were diluted appropriately and plated onto LB plates supplemented with 1 g/ml irgasan, which selects for Yersinia species. Plates were incubated at room temperature for 48 h and CFU enumerated using a ProtoCOL SR colony counter (Microbiology International). The remaining CFU samples were mixed 1:1 with 30% glycerol and frozen at Ϫ80°C. If no CFU were detected for a specific organ homogenate (i.e., were below the limit of detection by this method), samples were thawed and 300 to 400 l was added to LB supplemented with 1 g/ml irgasan and incubated at 26°C overnight with agitation. Cultures were plated onto LB supplemented with 1 g/ml irgasan and incubated at room temperature for 48 h to determine the presence or complete absence of any irgasan-resistant bacteria.
Determination of cytokine production by ELISA. BMDM supernatants and organ homogenates were thawed on ice and centrifuged at 13,000 rpm for 1 min. The mouse inflammatory cytometric bead array kit (BD Biosciences) was used to detect IL-12p70, TNF-␣, gamma interferon (IFN-␥), macrophage chemotactic protein 1 (MCP-1), IL-10, and IL-6 according to the manufacturer's instructions, except only 4 l of each antibody-conjugated bead, 20 l of sample or standard, and 20 l of phycoerythrin-conjugated detection reagent were used per reaction. Data were acquired using a FACSCalibur flow cytometer and CellQuest software 
RESULTS
Y. pseudotuberculosis infection induces TNF-␣, IFN-␥,
MCP-1, and IL-6 production in vivo, but IL-10 is detectable only during advanced stages of infection. The innate immune response to Y. pseudotuberculosis during disseminated disease in the mouse has not been well characterized. In order to investigate this response, we inoculated wild-type C57BL/6 mice i.p. with Y. pseudotuberculosis IP2666pIB1 and monitored CFU and cytokine levels in the spleen, liver, and serum at different times postinoculation (Fig. 1) . Robust growth was detected in both the spleen and liver during the time course, with an especially rapid CFU increase observed in the spleen between 48 and 72 h postinoculation (Fig. 1A) . During this time interval, we observed a sharp increase in the levels of IL-6, MCP-1, IFN-␥, and TNF-␣ in the spleen (Fig. 1B) . Lower overall levels of these four cytokines were detected in the liver during Yersinia infection (Fig. 1C) . The kinetics of serum cytokine production resembled that in the liver (Fig. 1D) . In contrast to previously published data with Y. enterocolitica serogroup O:8 strain WA-314 (51), there was no notable increase in IL-10 throughout the Y. pseudotuberculosis time course. These results are in accordance, however, with the reported lack of IL-10 in response to Y. pestis infection in the lung (23) .
At 72 h postinoculation, there appeared to be a small increase in IL-10 production in the liver (153 pg per gram tissue) (Fig. 1C) . However, this corresponded to less than 10 pg/ml of organ homogenate. This value is below the level required to obtain an accurate reading of cytokine production, as it falls within a nonlinear portion of the standard curve used for normalizing ELISA readings to cytokine concentrations (data not shown). homogenates did not uncover any detectable IL-10 (data not shown). We also obtained similar, negative results for IL-10 using the same detection system as in a previous study (51) that demonstrated IL-10 production during Y. enterocolitica infection of mice (data not shown) (see Materials and Methods). In order to determine whether IL-10 is induced by Y. pseudotuberculosis at later time points, the infection was allowed to progress until the animals were moribund (100 to 123 h postinoculation). Under these conditions, IL-10 was indeed detectable, with a concurrent further increase in the levels of TNF-␣, IFN-␥, MCP-1, and IL-6 (data not shown). We conclude that IL-10 can be detected only starting at 101 h postinoculation in terminally ill animals, more than 24 h after levels of other cytokines increased dramatically (Fig. 1B and C) .
Efficient growth of enteropathogenic Yersinia in a mouse strain lacking TLR2. Y. enterocolitica LcrV has been reported to induce IL-10 expression in a TLR2-dependent manner, and the Tlr2 Ϫ/Ϫ genotype has been described as resulting in reduced Y. enterocolitica growth in mouse tissues (50) . In order to determine the susceptibility of TLR2 Ϫ/Ϫ mice to Y. pseudotuberculosis, we performed i.p. infections of TLR2 Ϫ/Ϫ mice that were derived from a different Tlr2 construction than that used in the previous studies (48, 50, 51) and which had been completely backcrossed into the C57BL/6J background (54) . Surprisingly, these animals had levels of Y. pseudotuberculosis CFU similar to those in TLR2 ϩ/ϩ mice in both the liver and spleen at 4 days after i.p. inoculation ( Fig. 2A) spleen, P ϭ 0.78; liver, P ϭ 0.61).
To determine whether this lack of resistance of TLR2 Ϫ/Ϫ mice also showed no difference in resistance to Y. enterocolitica i.p. or oral infection (Fig. 2B and C) . In fact, there was a slight, but not statistically significant, trend towards susceptibility of TLR2 Ϫ/Ϫ mice to Y. enterocolitica via the i.p. route of infection ( Fig. 2B and C) (i.p. infection and spleen, P ϭ 0.13; i.p. infection and liver, P ϭ 0.08; oral infection and spleen, P ϭ 0.47; oral infection and liver P ϭ 0.1). This result is not a consequence of our Y. enterocolitica strain 8081 harboring a nonactivating lcrV allele, because the DNA sequence of the lcrV gene from this strain encodes the putative TLR2-activating K42 residue (data not shown).
We measured cytokine levels in the tissues of the infected animals from Fig. 2 . As we observed during the Y. pseudotuberculosis growth curve (Fig. 1) , TNF-␣, IFN-␥, MCP-1, and IL-6 were produced in both the spleens and livers of control and TLR2
Ϫ/Ϫ mice infected by the i.p. route with Y. pseudotuberculosis ( Fig. 3A and D) . Interestingly, while the CFU ranges of Y. pseudotuberculosis and Y. enterocolitica per gram of tissue were not statistically different after i.p. infection ( Fig.  2A and B ) (spleen, P ϭ 0.96; liver, P ϭ 0.12 [for wild-type mice]), we detected significantly less TNF-␣, IFN-␥, MCP-1, and IL-6 in Y. enterocolitica-infected tissues, with very low but significant levels of TNF-␣ and IFN-␥ in the spleen (Fig. 3B ) (P ϭ 0.02 and P ϭ 0.006, respectively, for wild-type mice compared to uninfected tissues) and no TNF-␣ or IFN-␥ detected in the liver (Fig. 3E ) (P ϭ 0.9 and P ϭ 0.3, respectively, for wild-type mice). In addition, the lowest levels of MCP-1 and IL-6 were detected during oral infection with Y. enterocolitica (Fig. 3C, F) , which correlated with lower bacterial burden (Fig. 2C) . Notably, there were no significant differences in TNF-␣ levels of wild-type and TLR2 Ϫ/Ϫ mice during all three enteropathogenic Yersinia infections. Furthermore, no IL-10 or IL-12p70 was detected in any of the conditions tested (Fig.  3) . The only observed statistically significant difference between the wild-type and TLR2 Ϫ/Ϫ animals described here was an 11-fold increase in IFN-␥ levels in the spleens, but not the To verify that TLR2 does not alter susceptibility of mice to Y. pseudotuberculosis under conditions of very advanced infection (when IL-10 is produced), we infected wild-type and TLR2
Ϫ/Ϫ mice with Y. pseudotuberculosis and let the infection progress for just over 100 h. By this time, the majority of mice in both groups showed symptoms of progressed disease (unpublished observations). The bacterial burdens in the spleen and liver remained similar between wild-type and TLR2 Ϫ/Ϫ animals ( Fig. 4A ) (spleen, P ϭ 0.4; liver, P ϭ 1). Importantly, IL-10 levels were identical in the presence or absence of TLR2 (Fig. 4B ) (spleen, P ϭ 0.4; liver, P ϭ 0.7). YopJ inhibits IL-10 expression during Y. pseudotuberculosis infection of macrophages. Previously published studies describing LcrV as a TLR2 ligand capable of inducing IL-10 and thereby suppressing TNF-␣ have used purified LcrV protein or peptide (48, 50) . In addition, the TTSS effector protein YopJ has been shown to suppress TNF-␣ directly (i.e., not through IL-10). In order to assess TNF-␣ and IL-10 expression during infection of macrophages with live Yersinia, we exposed TLR2 ϩ/Ϫ primary BMDMs to wild-type Y. pseudotuberculosis as well as Y. pseudotuberculosis lacking the virulence plasmid (pYV Ϫ ) or lacking only YopJ (⌬yopJ) for 2 hours and measured cytokine levels in the culture supernatant. As previously reported (9, 42) , TNF-␣ expression was suppressed by YopJ (Fig. 5A) . In the absence of YopJ, during infection with either the Y. pseudotuberculosis pYV Ϫ or ⌬yopJ strain, macrophages produced significant levels of both TNF-␣ and IL-10 ( Fig. 5A  and B) . IL-10 expression occurred independently of LcrV, since the pYV Ϫ strain lacks the lcrV gene. Heat-killed Y. pseudotuberculosis also induced macrophage TNF-␣ and IL-10 production (data not shown). These data suggest that IL-10 induction during infection of macrophages with live Yersinia results from activation of the TLR pathway by general TLR ligands such as LPS.
We also observed that wild-type Y. pseudotuberculosis induced five-and threefold less IL-10 than Y. pseudotuberculosis pYV Ϫ and ⌬yopJ, respectively (Fig. 5B) , indicating that the TTSS effector protein YopJ normally suppresses IL-10 production. Y. pseudotuberculosis pYV Ϫ induced significantly more IL-10 than the ⌬yopJ mutant (P ϭ 0.03), perhaps because multiple plasmid-encoded determinants inhibit IL-10 expression. In regard to TNF-␣, the pYV Ϫ and ⌬yopJ strains showed the opposite relationship. Both strains demonstrated the known alleviation of TNF-␣ suppression seen when YopJ is absent. However, macrophages produced more TNF-␣ in re- on October 15, 2017 by guest http://iai.asm.org/ sponse to the ⌬yopJ mutant than the pYV Ϫ strain (Fig. 5A ) (P ϭ 0.095). This may be due to lower IL-10 levels in the supernatants of macrophages infected with the ⌬yopJ strain (Fig. 5B) , leading to a decrease in IL-10-mediated suppression of TNF-␣.
We next compared TNF-␣ and IL-10 levels in the supernatants of TLR2 (Fig. 5C) . Collectively, these results demonstrate that (i) Yersinia lacking LcrV induces IL-10, (ii) this induction is TLR2 independent, (iii) fully virulent Yersinia actively inhibits IL-10 expression, and (iv) this IL-10 suppression is at least partially dependent upon the type III secreted effector protein YopJ.
The presence or absence of YopJ does not affect Y. pseudotuberculosis burden or cytokine levels in mouse tissues after i.p. infection. To determine whether Yersinia lacking YopJ induces IL-10 in mouse tissues, we infected wild-type C56BL/6 mice via the i.p. route with Y. pseudotuberculosis ⌬yopJ. We observed no significant defect in Y. pseudotuberculosis growth in the spleens or livers of mice at 4 days postinoculation (Fig. 5D) . While all mice infected with wild-type Y. pseudotuberculosis survived up to 4 days postinoculation (7/7), only 71% survived infection with Y. pseudotuberculosis ⌬yopJ (10/14). However, there was no overall difference between the wild-type and ⌬yopJ strains in TNF-␣, IL-10, IL-12p70, IL-6, MCP-1, or IFN-␥ levels in either the spleen or liver at this time point (Table 1 and data not shown). The lack of IL-10 in Y. pseudotuberculosis ⌬yopJ-infected tissues may indicate that additional plasmid-associated factors distinct from YopJ, which contribute to IL-10 suppression in culture (Fig. 5B) , may be sufficient for IL-10 suppression in mouse tissues.
DISCUSSION
Human pathogenic Yersinia species manipulate target cell signaling pathways in order to facilitate growth in a variety of tissue sites (10) . One current model suggests that the engagement of the innate immune sensor TLR2 by the TTSS component LcrV leads to such misregulation and that this facilitates growth of the microorganism within host tissues (10, 17, 22, 50) . Specifically, LcrV binding to TLR2 leads to activation of the anti-inflammatory cytokine IL-10, resulting in lowered production of the inflammatory cytokine TNF-␣ and thus increased bacterial replication (50) . In support of this model, it has been reported that two out of three mouse strains tested that lack TLR2 are resistant to Y. enterocolitica infection (50, 51) . However, several aspects of this proposed pathway are inconsistent with the data presented here. A TLR2 Ϫ/Ϫ mouse strain, which was derived from a different parent strain than that used in previous Yersinia infection studies, did not demonstrate enhanced resistance to two enteropathogenic Yersinia species after either oral or i.p. inoculation. Moreover, expression of IL-10 and TNF-␣ was similar between TLR2 Ϫ/Ϫ and TLR2 ϩ/ϩ mice during enteropathogenic Yersinia infection. In fact, translocated substrates of the Yersinia TTSS appeared to actively suppress macrophage IL-10. Furthermore, we observed that Y. pseudotuberculosis induced macrophage IL-10 expression independently of TLR2 and LcrV in the absence of TTSS translocated effectors.
The pleiotropic effects of LcrV on Yersinia virulence make it challenging to tease apart its direct and indirect effects on the host and make it impossible to test an lcrV null mutant to address specific contributions to virulence. A mutant Yersinia strain lacking LcrV misregulates effector Yops and is incapable of translocating the Yops that are produced into target host cells (13, 34, 39, 44) . In addition, purified Y. enterocolitica LcrV (or presumably LcrV secreted from bacterial cells during an infection) can stimulate cultured cells in a TLR2-dependent manner (50) . However, in the presence of live Yersinia, which produces a number of other TLR ligands and harbors the immunomodulatory TTSS, the LcrV-TLR2 interaction may not have a strong or straightforward effect on the innate immune system.
Enhanced pathogen resistance of mice lacking TLR2 has rarely been reported, as most studies indicate that TLR2 Ϫ/Ϫ mice either behave similarly to the wild type in this regard or are more susceptible to a number of different pathogens (21, 28, 53, 55) . Indeed, TLR2
Ϫ/Ϫ and TLR2 ϩ/ϩ mice are equally susceptible to Y. pestis (K. Pouliot and J. Goguen [University of Massachusetts, Worcester], personal communication). One notable exception is a report that showed decreased susceptibility of TLR2 Ϫ/Ϫ mice to the fungal pathogen Candida albicans (38) . In contrast, two other publications demonstrated that TLR2
Ϫ/Ϫ mice derived from a different Tlr2 knockout construction either were more susceptible to C. albicans infection (59) or were unaffected (6) compared to wild-type control animals. This discrepancy is strikingly similar to the results found here and to those previously reported for Y. enterocolitica strain WA-314 (50) . In fact, the mouse knockout line that shows decreased susceptibility to C. albicans is identical to the strain used in the previous Y. enterocolitica studies showing a similar phenotype (50) . This indicates that either the nature of the genetic construction or the genetic background harboring the TLR2 Ϫ/Ϫ genotype could affect the results obtained with these knockout lines. Consistent with this proposition, a previous report indicates that backcrossing the Tlr2 mutation into the C3H murine genetic background reverses the Y. enterocolitica susceptibility properties of the mouse (51) . Furthermore, the fact that TLR2 Ϫ/Ϫ C3H mice no longer restrict Y. enterocolitica growth but still display decreased splenic IL-10 compared to wild-type control animals (51) indicates that de- (49) . However, IL-10 Ϫ/Ϫ mice have an increased incidence of inflammatory diseases such as inflammatory bowel disease (2), so increased resistance to pathogens seems to come at the price of aberrant inflammation. IL-10 expression is induced by the TLR pathway upon recognition of TLR ligands, such as LPS, along with inflammatory cytokines, such as TNF-␣ (1, 18) . This may be a mechanism by which inflammation downstream of TLRs is kept in check, since IL-10 could serve to dampen further expression of inflammatory cytokines, such as TNF-␣. Our findings that Y. pseudotuberculosis lacking LcrV induces TLR2-independent IL-10 expression in vitro and that IL-10 is produced in both wild-type and TLR2
Ϫ/Ϫ mice at late stages of Y. pseudotuberculosis infection suggest that other TLRs (such as TLR4) recognize general TLR ligands on Yersinia (such as LPS), leading to a general TLR response which includes IL-10.
The possibility remains that, in contrast to the case for Y. pseudotuberculosis, the late stages of Y. enterocolitica infection could result in IL-10 levels that are dependent on TLR2, leading to a less restrictive environment to Y. enterocolitica growth when TLR2 is present. However, we could not detect IL-10 in the tissues of Y. enterocolitica-infected C57BL/6 mice as late as 8 days after i.p. inoculation (data not shown). In addition, we observed a trend towards enhanced susceptibility to Y. enterocolitica of TLR2 Ϫ/Ϫ mice compared to TLR2 ϩ/ϩ mice at 4 days postinoculation (Fig. 2B) , as did Sing et al. when infections were performed in the C3H mouse background (51) . Another possibility is that some strains of Y. enterocolitica (such as WA-314) may induce IL-10 earlier during infection of mice. Further studies comparing different Y. enterocolitica strains are needed to address this possibility.
The lack of IL-10 in Y. pseudotuberculosis-infected tissues until very late stages of infection is consistent with the clinical manifestations of Yersinia-induced enterocolitis in humans. Enteropathogenic Yersinia causes inflammatory diarrhea which can be associated with fever and swelling of gastric tissues and lymph nodes (19) . These disease manifestations do not suggest a major role for induction of anti-inflammatory cytokines as a virulence mechanism of enteropathogenic Yersinia.
Two previously published reports support our data showing that the TTSS effector protein YopJ can inhibit macrophage IL-10 expression. Erfurth et al. (12) showed that dendritic cells produced IL-10 upon exposure to Y. enterocolitica either lacking the virulence plasmid or lacking only the yopJ homolog, yopP, but not upon exposure to wild-type Y. enterocolitica strain WA-314. In addition, Zhang et al. (61) reported that IL-10 was differentially expressed by macrophages after exposure to Y. pseudotuberculosis encoding either catalytically active or dead YopJ. Although the exact nature of the catalytic activity of YopJ/P is controversial (30, 35, 40, 62) , the action of the protein clearly leads to inhibition of the NF-B and mitogenactivated protein kinase (MAPK) pathways (9, 42, 47) . While IL-10 expression is independent of NF-B, MAPKs are thought to play a role (25) (26) (27) . Inhibition of the MAPK pathway by YopJ may explain the ability of this effector protein to suppress IL-10 expression. In addition to YopJ, other plasmidencoded determinants contribute to IL-10 suppression in vitro (Fig. 5B) and may be sufficient for IL-10 suppression in vivo (Table 1) . Whether IL-10 suppression is an important virulence mechanism for enteropathogenic Yersinia remains to be determined and awaits discovery of these other putative factors that suppress IL-10 secretion.
The contribution of the TTSS effector protein YopJ to virulence seems to vary depending on the Yersinia species and route of entry. Y. pestis lacking yopJ has been reported to possess no virulence defect, whereas a Y. enterocolitica yopJ mutation was shown to lower virulence via both the oral and intravenous routes of infection (24, 52, 57) . The role of YopJ in Y. pseudotuberculosis infection has been studied via the oral route, but the published results are conflicting (15, 31) . In this study we showed that a yopJ mutant was identical to Y. pseudotuberculosis expressing YopJ in terms of bacterial burden following i.p. infection. However, we did observe increased mortality in the mouse groups that received the ⌬yopJ strain compared to those that received Y. pseudotuberculosis expressing YopJ. This was not a result of increased inflammation in the mice infected with the ⌬yopJ mutant, because TNF-␣, IFN-␥, IL-6, and MCP-1 levels were similar between both groups of mice (Table 1 and data not shown), even though the ⌬yopJ mutant induced threefold more TNF-␣ than wild-type bacteria in cell culture (Fig. 5B) . Whether TNF-␣ suppression by YopJ is an important virulence mechanism in vivo remains to be determined.
Further studies will be required to determine which innate immune sensors participate in detecting and mounting an efficient immune response to Yersinia. In addition, understanding how these immune responses are manipulated by the Yersinia TTSS and how this relates to virulence in vivo will be important in deciphering this complex host-microbe interaction.
